Renascience - Crunchbase Company Profile & Funding

Q: Where is Renascience's headquarters?

Renascience is located in Tokyo, Tokyo, Japan.

Q: Who invested in Renascience?

Renascience has 6 investors including Otsuka Holdings And DCI Partners.

Q: When was the last funding round for Renascience?

Renascience closed its last funding round on obfuscated from a Series B round.

Q: How much funding has Renascience raised to date?

Renascience has raised obfuscated.

Overview

Renascience

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Renascience

CB Rank

146153

Renascience is a research and development firm that creates treatments to solve medical issues and manufactures pharmaceuticals.

Founded

obfuscation

Private

Series B

Tokyo, Tokyo, Japan

11-50

www.renascience.co.jp/

Clinical Trials

Health Care

Health Diagnostics

Medical

Funding Rounds

Series B

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Series A

OBF

obfuscation

Key People

Toshio Miyata: Director & Founder
Ando Hidehiro: Auditor

Details

Legal Name

Renascience Inc

Also Known As

レナサイエンス

Operating Status

Active

Company Type

For Profit

Founders

Kiyoshi Kurokawa, Toshio Miyata

About the Company

Renascience is a pharmaceuticals company.

Phone Number

+81 22-727-5070

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

PAI-1 Inhibitor RS5614

An oral small molecule drug that inhibits PAI-1 to enhance immune response against tumors and improve cancer treatment outcomes.

RS8001 (Pyridoxamine)

A drug under joint development for treating mental symptoms associated with premenstrual syndrome and premenstrual dysphoric disorder.

Research & Development

Renascience is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Renascience	3	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Renascience	3	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Renascience	3	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Renascience	3	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Renascience	3	obfuscated obfuscation	—	Series B

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Renascience	3	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Renascience	3	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Renascience	3	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Renascience	3	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Renascience	3	obfuscated obfuscation	—	Series B

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Otsuka Holdings	—	Series B - Renascience	—
Otsuka Holdings	—	Series B - Renascience	—
Otsuka Holdings	—	Series B - Renascience	—
Otsuka Holdings	—	Series B - Renascience	—
Otsuka Holdings	—	Series B - Renascience	—